Immunic | VTL - Net Income


Immunic reported $-19.3M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Alterity Therapeutics Limited AUD -6.3M 525.41K Dec/2025
BioMarin Pharmaceutical USD 105.53M 152.1M Mar/2026
Cipla INR 5.55B 1.21B Mar/2026
Clal Biotechnology ILS -6.17M 15.56M Dec/2022
Compugen USD 56.84M 63.82M Dec/2025
CSL USD 401M 96.5M Dec/2025
Enanta Pharmaceuticals USD -22.29M 93.76M Dec/2024
Grifols EUR 114.37M 34.03M Dec/2025
Immunic USD -19.3M 6.28M Dec/2025
Insmed USD -163.56M 164.92M Mar/2026
Omeros USD -32.23M 23.81M Sep/2024
OraSure Technologies USD -19.29M 5.57M Dec/2025
Quidel USD -91.8M 38.9M Mar/2026
Ultragenyx Pharmaceutical USD -185M 56M Mar/2026
United Therapeutics USD 274.9M 89.4M Mar/2026
Xoma USD -17.24M 33.23M Sep/2024